Prothena Corporation News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

06.04.15	Prothena Announces Proposed Offering of Ordinary Shares (GlobeNewswire)
20.03.15	FOLD Expands, CERU Hits A High, FDA Panel Verdict Out On Breo Ellipta (RTTNews)
19.03.15	Prothena Surges On Positive Phase I Results Of Parkinson's Drug PRX002 (RTTNews)
19.03.15	Prothena Reports Robust Reduction of Free Serum Alpha-Synuclein of up to 96% After Single Dose of PRX002, a Novel Protein Immunotherapy for Parkinson's Disease (GlobeNewswire)
06.03.15	GALE On The Radar, CALA Surges After-Hours, Capricor Uplisted, CPRX On A High (RTTNews)
05.03.15	Prothena Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Financial Guidance and R&D Update (GlobeNewswire)
19.02.15	Prothena to Report Fourth Quarter and Full Year 2014 Financial Results and Host Webcast and Conference Call on March 5 (GlobeNewswire)
18.02.15	Prothena to Present at the 2015 RBC Capital Markets' Healthcare Conference in New York on February 25 (GlobeNewswire)
15.12.14	Prothena Receives FDA Fast Track Designation for NEOD001, a Monoclonal Antibody for the Treatment of Patients With AL Amyloidosis (GlobeNewswire)
08.12.14	Prothena to Present at the Oppenheimer 25th Annual Healthcare Conference in New York (GlobeNewswire)
02.12.14	Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis (GlobeNewswire)
04.11.14	GALE's Present & Future, HNSN, CSII Products Get CE Mark, EBIO On Track (RTTNews)
03.11.14	Prothena Reports Third Quarter 2014 Financial Results and R&D Progress (GlobeNewswire)
25.06.14	Prothena Prices Public Offering Of 4.75 Mln Ordinary Shares At $22.50/shr (RTTNews)
06.05.14	MusclePharm Flexes Muscles, PRTA Surges After-hours, TXMD Hopes To Deliver (RTTNews)
09.04.14	ALKS, SGEN To Watch Out, Capstone Dons New Hat, PRTA Pockets $15 Mln (RTTNews)
19.03.14	AERI On Watch, LPCN To Be Uplisted, NVGN Back In Focus, PRTA Up After Hours (RTTNews)
03.10.13	Prothena Prices Offering Of 5.91 Mln Shares At $22/shr - Quick Facts (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	137.35	1.40 %	K V
Sonova Hldg	297.30	1.29 %	K V
Logitech Intl	74.86	1.22 %	K V
Nestle	75.22	1.02 %	K V
Alcon	76.32	0.95 %	K V
UBS Group	28.17	-0.67 %	K V
Swiss Re	131.95	-0.68 %	K V
Geberit	533.80	-0.78 %	K V
Lonza Grp	541.40	-0.81 %	K V
Kuehne+Nagel Int	202.60	-1.65 %	K V